Clinical Trial Update: RAD001 (Everolimus) + Docetaxel + Cisplatin as Induction Chemotherapy in Patients With Local-Regional Advanced Head and Neck Cancer [Phase 1]

View source ↗

Summary

This clinical trial update reports on a Phase 1 study evaluating everolimus plus docetaxel and cisplatin as induction chemotherapy for locally advanced head and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)
• Everolimus (everolimus)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: HEAD & NECK Cancer | Phase 1 | Status: COMPLETED